Peptides and peptidomimetics as regulators of protein-protein interactions.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Opinion in Structural Biology

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.sbi.2016.12.009PMID 28063303PMCID PMC5496809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation.

  2016cited by this paper
• Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo.

  2016cited by this paper
• Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein-Protein Interaction Inhibitor Reveals a Non-catalytic Role for GAPDH Oligomerization in Cell Death*

  2016cited by this paper
• Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors

  2016cited by this paper
• Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics.

  2016cited by this paper
• Clinical Overview of MDM2/X-Targeted Therapies

  2016cited by this paper
• Advancement and applications of peptide phage display technology in biomedical science

  2016cited by this paper
• Designing helical peptide inhibitors of protein-protein interactions.

  2016cited by this paper
• Advances in phage display technology for drug discovery

  2015cited by this paper
• Alternative modulation of protein–protein interactions by small molecules

  2015cited by this paper
• Peptide therapeutics: current status and future directions.

  2015cited by this paper
• Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell

  2015cited by this paper
• Exploration of the HIF-1α/p300 interface using peptide and Adhiron phage display technologies.

  2015cited by this paper
• Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes

  2015cited by this paper
• High-throughput methods for identification of protein-protein interactions involving short linear motifs

  2015cited by this paper
• Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

  2014cited by this paper
• Fundamental Molecular Mechanism for the Cellular Uptake of Guanidinium-Rich Molecules

  2014cited by this paper
• Constrained peptides with target-adapted cross-links as inhibitors of a pathogenic protein-protein interaction.

  2014cited by this paper
• Characterizing WW Domain Interactions of Tumor Suppressor WWOX Reveals Its Association with Multiprotein Networks*

  2014cited by this paper
• Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.

  2014cited by this paper
• α-Helix mimetics: outwards and upwards.

  2014cited by this paper
• A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity

  2013cited by this paper
• Phage display as a technology delivering on the promise of peptide drug discovery.

  2013cited by this paper
• Protein-protein interactions in drug discovery

  2013cited by this paper
• Druggable protein-protein interactions--from hot spots to hot segments.

  2013cited by this paper
• Stapled peptides for intracellular drug targets.

  2012cited by this paper
• Development and Therapeutic Applications of Oligonucleotides and Peptides

  2012cited by this paper
• Peptide based Molecules as Protein-Protein Interaction Inhibitors: Tools for Chemical Genetics and Therapy

  2012cited by this paper
• Protein kinase C, an elusive therapeutic target?

  2012cited by this paper
• RACK1, A multifaceted scaffolding protein: Structure and function

  2011cited by this paper
• Decorating microbes: surface display of proteins on Escherichia coli.

  2011cited by this paper
• Lambda-Display: A Powerful Tool for Antigen Discovery

  2011cited by this paper
• Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

  2011cited by this paper
• Aberrant mitochondrial fission in neurons induced by protein kinase Cδ under oxidative stress conditions in vivo

  2011cited by this paper
• Regulation of PKC by Protein–Protein Interactions in Cancer

  2010cited by this paper
• Highly Specific Modulators of Protein Kinase C Localization: Applications to Heart Failure.

  2010cited by this paper
• Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective.

  2010cited by this paper
• Rationally designed peptide regulators of protein kinase C.

  2009cited by this paper
• Isolation of human monoclonal antibodies by mammalian cell display

  2008cited by this paper
• The exploration of macrocycles for drug discovery — an underexploited structural class

  2008cited by this paper
• Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

  2008cited by this paper
• Mechanisms of specificity in protein phosphorylation

  2007cited by this paper
• Mechanisms of specificity in protein phosphorylation

  2007cited by this paper
• Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits.

  2006cited by this paper
• In vitro display technologies reveal novel biopharmaceutics

  2006cited by this paper
• Are protein–protein interfaces more conserved in sequence than the rest of the protein surface?

  2004cited by this paper
• Yeast cell-surface display—applications of molecular display

  2004cited by this paper
• Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase

  2003cited by this paper
• The RACK1 scaffold protein: a dynamic cog in cell response mechanisms.

  2002cited by this paper
• Phage display: practicalities and prospects

  2002cited by this paper
• In vivo protein transduction: delivery of a biologically active protein into the mouse.

  1999cited by this paper
• Peptide modulators of protein–protein interactions in intracellular signaling

  1998cited by this paper
• An evolutionary trace method defines binding surfaces common to protein families.

  1996cited by this paper
• Intracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme.

  1991cited by this paper
• Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

  1985cited by this paper

• Biofilm-Resistant Infections: Innovative Inhibitors and Treatment Strategies

  2026cites this paper
• Unraveling structure–function relationships and antioxidant stability of Ferula assafoetida seed protein hydrolysates with physicochemical and sensory characterization

  2026cites this paper
• A Review of Current Computational Tools for Peptide–Protein Docking

  2026cites this paper
• Structure‐Guided Synthetic Peptide Targeting Nucleolus and Neural Progenitor Protein Nuclear Import Impairs Ribosome Biogenesis and Cancer Cell Proliferation

  2026cites this paper
• Mapping Native Peptide-Peptide Noncovalent Interactions: Insights from Trapped Ion Mobility Spectrometry, Electron- and UV-Fragmentation, Tandem Mass Spectrometry, and Molecular Dynamics.

  2026cites this paper
• Targeting Oncogenic STAT3 Pathways in Osteosarcoma With Serratia marcescens Peptides

  2026cites this paper
• PepScorer::RMSD: An Improved Machine Learning Scoring Function for Protein–Peptide Docking

  2026cites this paper
• Guiding Peptide Kinetics via Collective-Variable Tuning of Free-Energy Barriers

  2026cites this paper
• Inhibiting MARCH5/Mfn2 signaling as an alternative strategy to protect cardiomyocytes from hypoxia-induced mitochondrial dysfunction

  2025cites this paper
• β‐Cyclodextrin Inclusion Complexes with Model Pentapeptides: Role of the Tyrosine Position within the Peptide Chain

  2025cites this paper
• Applying RSM for optimization of Ferula assafoetida protein hydrolysis to enhance bioactivity and functional properties

  2025cites this paper
• Physicochemical stability, antioxidant and ACE-inhibitory activities of cryoprotected liposomes encapsulating stone fish-derived peptides

  2025cites this paper
• The Potential of Peptide-Based Inhibitors in Disrupting Protein–Protein Interactions for Targeted Cancer Therapy

  2025cites this paper
• Peptidomimetics design and characterization: Bridging experimental and computer-based approaches.

  2025cites this paper
• Affinity selection–mass spectrometry with linearizable macrocyclic peptide libraries

  2025cites this paper
• Explore peptides extracted from gliadin hydrolysates suppressing BACE1 activity and restraining Aβ protein deposition.

  2025cites this paper
• Peptide Multifunctionalization via Modular Construction of Trans‐AB2C Porphyrin on Resin

  2025cites this paper
• A non-hydrolysable peptidomimetic for mitochondrial targeting.

  2025cites this paper
• Modulating the phosphorylation status of target proteins through bifunctional molecules.

  2025cites this paper
• Sustainable plant-based protein hydrolysates: Utilization of waste proteins modified by enzymatic hydrolysis in techno-functional applications.

  2025cites this paper
• Ligand-Directed Site-Selective Cysteine Bioconjugation of the KELCH Domain of KEAP1 with Hypervalent Iodine Reagents

  2025cites this paper
• Peptide halogenation biochemistry: interfacing pharmaceutical deliverables with chemical innovation

  2025cites this paper
• Protein Recognition of Linear and Cyclic Peptides of Homologous Sequences Implicated in the Aggregation of α‑Synuclein

  2025cites this paper
• Harnessing deep statistical potential for biophysical scoring of protein-peptide interactions

  2025cites this paper
• Optimization of enzymatic hydrolysis for obtaining antioxidant hydrolysates from pumpkin seed protein: Improvement of the physicochemical, structural and functional properties

  2025cites this paper
• Advances in clinical studies of peptide drugs in stroke disease.

  2025cites this paper
• Peptides Targeting the IF1–ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells

  2024cites this paper
• Identification for Antioxidant Peptides in Porcine Liver and Heart Hydrolysates Using SWATH-MS Analysis

  2024cites this paper
• Impairing protein–protein interactions in an essential tRNA modification complex: An innovative antimicrobial strategy against Pseudomonas aeruginosa

  2024cites this paper
• Sickle Cell Hemoglobin “Drugged” with Cyclic Peptides Is Aggregation Incompetent

  2024cites this paper
• Cardiac troponin I directly binds and inhibits mitochondrial ATP synthase with a noncanonical role in the post-ischemic heart

  2024cites this paper
• Blood-supplementing effect of low molecular weight peptides of E-Jiao on chemotherapy-induced myelosuppression: evaluation of pharmacological activity and identification of bioactive peptides released in vivo

  2024cites this paper
• Structure-guided design and cloning of peptide inhibitors targeting CDK9/cyclin T1 protein-protein interaction

  2024cites this paper
• Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium

  2024cites this paper
• Deciphering ACE2-RBD binding affinity through peptide scanning: A molecular dynamics simulation approach

  2024cites this paper
• Peptide-encoding gene transfer to modulate intracellular protein-protein interactions

  2024cites this paper
• The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis

  2024cites this paper
• Cardiac Troponin I Directly Binds and Inhibits Mitochondrial ATP Synthase: a Noncanonical Role in the Post-Ischemic Heart

  2023cites this paper
• An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases

  2023cites this paper
• Photoresponsive peptide materials: Spatiotemporal control of self-assembly and biological functions

  2023cites this paper
• An Update on Protein Kinases as Therapeutic Targets—Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein–Protein Interactions

  2023cites this paper
• Transcription factors in the development and treatment of immune disorders

  2023cites this paper
• Electrophile Scanning Reveals Reactivity Hotspots for the Design of Covalent Peptide Binders.

  2023cites this paper
• Cyclic Peptides as Aggregation Inhibitors for Sickle Cell Disease.

  2023cites this paper
• Current Computational Methods for Protein-Peptide Complex Structure Prediction.

  2023cites this paper
• Visualising instance selection for improved explainability using feature extraction

  2023cites this paper
• Developing a peptide to disrupt cohesin head domain interactions

  2023cites this paper
• Conformationally constrained cyclic grafted peptidomimetics targeting protein–protein interactions

  2023cites this paper
• Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery

  2023cites this paper
• Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma

  2023cites this paper
• Predicting Protein-Peptide Interactions: Benchmarking Deep Learning Techniques and a Comparison with Focused Docking

  2023cites this paper
• The WW domain of IQGAP1 binds directly to the p110α catalytic subunit of PI 3-kinase

  2023cites this paper
• Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia

  2023cites this paper
• Targeting Protein–Protein Interfaces with Peptides: The Contribution of Chemical Combinatorial Peptide Library Approaches

  2023cites this paper
• Rational peptide design for inhibition of the KIX–MLL interaction

  2023cites this paper
• In silico Investigation of Lon Protease as a Promising Therapeutic Target.

  2022cites this paper
• Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd

  2022cites this paper
• Prediction and Modeling of Protein–Protein Interactions Using “Spotted” Peptides with a Template-Based Approach

  2022cites this paper
• An albumin scaffold grafted with an alpha-helical motif delivers therapeutic payloads by modular coiled-coil assembly.

  2022cites this paper
• Computational Tools and Strategies to Develop Peptide-Based Inhibitors of Protein-Protein Interactions.

  2022cites this paper
• Abiotic Synthetic Antibodies to Target a Specific Protein Domain and Inhibit Its Function.

  2022cites this paper
• A novel mRNA decay inhibitor abolishes pathophysiological cellular transition

  2022cites this paper
• Deciphering of a Putative GPER Recognition Domain in ERα and ERα36

  2022cites this paper
• Design of peptide-based foldamers for inhibiting the Hdm2-p53 interaction using backbone modification: a molecular dynamics study

  2022cites this paper
• Des3PI: a fragment-based approach to design cyclic peptides targeting protein–protein interactions

  2022cites this paper
• On-resin peptide modification of methionine residue by employing 2-bromoacetate derivatives

  2022cites this paper
• Structure-Based Design, Optimization, and Evaluation of Potent Stabilized Peptide Inhibitors Disrupting MTDH and SND1 Interaction.

  2022cites this paper
• KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

  2022cites this paper
• Synthesis of natural product hybrids by the Ugi reaction in complex media containing plant extracts

  2022cites this paper
• Binary combinatorial scanning reveals potent poly-alanine-substituted inhibitors of protein-protein interactions

  2022influential citation
• Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate

  2022cites this paper
• Peptide-based LDH5 inhibitors enter cancer cells and impair proliferation

  2022cites this paper
• Don't let go - co-fractionation mass spectrometry for untargeted mapping of protein-metabolite interactomes.

  2022cites this paper
• Designing Cell-Permeable Peptide Therapeutics That Enter the Cell by Endocytosis.

  2022cites this paper
• Effects and mechanisms of Eps 8 on the biological behaviour of malignant tumours ( Review )

  2021cites this paper
• Improving Docking Power for Short Peptides Using Random Forest

  2021cites this paper
• Protein Macrocyclization for Tertiary Structure Stabilization

  2021cites this paper
• Construction of diverse peptide structural architectures via chemoselective peptide ligation

  2021cites this paper
• Methods for Molecular Modelling of Protein Complexes.

  2021cites this paper
• Rational Design of Peptide-Based Inhibitors Disrupting Protein-Protein Interactions

  2021cites this paper
• In silico Approaches for the Design and Optimization of Interfering Peptides Against Protein–Protein Interactions

  2021cites this paper
• Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2

  2021cites this paper
• Bicyclic β‐Sheet Mimetics that Target the Transcriptional Coactivator β‐Catenin and Inhibit Wnt Signaling

  2021cites this paper
• NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells

  2021cites this paper
• Designed β-Hairpins Inhibit LDH5 Oligomerization and Enzymatic Activity.

  2021cites this paper
• Evaluation of Computationally Designed Peptides against TWEAK, a Cytokine of the Tumour Necrosis Factor Ligand Family

  2021cites this paper
• Effects and mechanisms of Eps8 on the biological behaviour of malignant tumours

  2021cites this paper
• Exploring the chemical space of protein–protein interaction inhibitors through machine learning

  2021cites this paper
• Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19

  2021cites this paper
• Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases

  2021cites this paper
• Rational Design of Constrained Peptides as Protein Interface Inhibitors

  2021cites this paper
• Peptide‐Based Inhibitors for SARS‐CoV‐2 and SARS‐CoV

  2021cites this paper
• Intracellular Delivery of Antibodies for Selective Cell Signaling Interference

  2021cites this paper
• Structure and activity of the DHNA Coenzyme-A Thioesterase from Staphylococcus aureus providing insights for innovative drug development

  2021cites this paper
• Peptides and Peptidomimetics as Foundations for Drug Discovery

  2021cites this paper
• Deep Alanine Scanning Reveals Potent Multi-alanine-substituted Protein–protein Interaction Inhibitors

  2021cites this paper
• Design of Pseudodiproline Dimers as Mimetics of Pro-Pro Units: Stereocontrolled Synthesis, Configurational Relevance, and Structural Properties.

  2021cites this paper
• Peptides and peptidomimetics as therapeutic agents for Covid‐19

  2021cites this paper
• Diarylethene moiety as an enthalpy-entropy switch: photoisomerizable stapled peptides for modulating p53/MDM2 interaction.

  2020cites this paper
• Principles and applications of small molecule peptidomimetics

  2020cites this paper